FDA Clearance Tracker · P970051-S048
NUCLEUS COCHLEAR IMPLANT SYSTEM
Last checked: Nov 20, 2026Latest source record: Aug 28, 2009 (this decision)Source: openFDAMethods & limitations
Decided
Aug 28, 2009
Approved
Time to decision
276 days
Received Nov 25, 2008. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P970051-S048
- Device name
- NUCLEUS COCHLEAR IMPLANT SYSTEM
- Applicant
- Cochlear Americas
- Applicant location
- Lone Tree, CO
- Received
- Nov 25, 2008
- Decided
- Aug 28, 2009
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P970051
Device type
- Device type
- Implant, cochlear (MCM)
- Device class
- Class III
- Specialty
- Otolaryngology (ENT)
FDA's approval statement
As written in FDA's record.
APPROVAL FOR THE CI512 AND CI513 COCHLEAR IMPLANTS. THE CI512 AND CI513 IMPLANTS REPRESENT MODIFICATIONS TO THE NUCLEUS FREEDOM COCHLEAR IMPLANT (ALSO CALLED THE CI24RE).
Source documents
Other decisions for Cochlear Americas
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K260902 · Decided Jul 10, 2026 · 114 days after receipt
Device type: Active Implantable Bone Conduction Hearing System (PFO) · Otolaryngology (ENT)
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.